Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 376–400 of 7,816 matching trials · page 16 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Using the EHR to Advance Genomic Medicine Across a Diverse Health System NCT06377033 Behavioral nudge Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | University of Pennsylvania OTHER |
2026-08-14 |
|
SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden NCT06708182 SAGE LEAF Positive Emotion Skills Course Runs in: United States · 1 site |
NA other |
COMPLETED | 53 | Northwestern University OTHER |
2026-08-14 |
|
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia NCT07284472 EXV-802; Placebo; EXV-801 Runs in: Canada; Czechia; Germany; Italy; Poland; Slovakia; Spain;... · 49 sites |
PHASE2|PHASE3 other |
RECRUITING | 300 | Exciva GmbH INDUSTRY |
2026-08-14 |
|
Medication Collaboration Feasibility Study NCT07742189 Medication Collaboration Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Northwestern University OTHER |
2026-08-14 |
|
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection NCT07764679 [18F]Fluorbetazine injection Runs in: China · 1 site |
PHASE3 other |
RECRUITING | 400 | HTA Co., Ltd. INDUSTRY |
2026-08-14 |
|
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation NCT05557409 AXS-05; Placebo Runs in: Puerto Rico; United States · 55 sites |
PHASE3 other |
COMPLETED | 408 | Axsome Therapeutics, Inc. INDUSTRY |
2026-08-13 |
|
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) NCT06064890 Intrathalamic AAV.PGRN administration; Intrathalamic AVB-101 Runs in: Belgium; Canada; Italy; Netherlands; Poland; Spain; Swede... · 19 sites |
PHASE1|PHASE2 gene-therapy |
RECRUITING | 18 | AviadoBio Ltd INDUSTRY |
2026-08-13 |
|
Multimodal Assesment of Alzheimer Patients NCT06448403 MRI Scanning; 64-channel EEG; Polysomnography; Blood samples; Fecal... Runs in: Norway · 1 site |
NA other |
RECRUITING | 60 | Norwegian University of Science and Technology OTHER |
2026-08-13 |
|
Memory Deterioration in Alzheimer Disease NCT07118137 7T MRI; EEG; Blood samples; Stool samples; Neuropsychologic test (MoCA) Runs in: Norway · 1 site |
NA other |
RECRUITING | 30 | Norwegian University of Science and Technology OTHER |
2026-08-13 |
|
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1 NCT07217665 AADvac1; Matching Placebo Runs in: United States · 1 site |
PHASE2 other |
ENROLLING_BY_INVITATION | 146 | Adam Boxer OTHER |
2026-08-13 |
|
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease NCT07659964 Metronome Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | Boston University Charles River Campus OTHER |
2026-08-13 |
|
A Post Authorization Registry Study of Participants Treated With LEQEMBI NCT07762092 No Intervention Runs in: Canada · 11 sites |
NA anti-amyloid-antibody |
NOT_YET_RECRUITING | 400 | Eisai Limited INDUSTRY |
2026-08-13 |
|
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairment NCT07762235 Dual-Task-Based High-Amplitude Functional Exercise Program; Traditi... |
NA other |
NOT_YET_RECRUITING | 36 | Istinye University OTHER |
2026-08-13 |
|
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy NCT03503331 [C-11]PiB-PET/MRI Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 160 | University of Alabama at Birmingham OTHER |
2026-08-12 |
|
UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy NCT03809351 [F-18]AV-1451-PET Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 160 | University of Alabama at Birmingham OTHER |
2026-08-12 |
|
The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities NCT04732052 Transcranial Direct Current Stimulation Runs in: Canada · 1 site |
NA other |
RECRUITING | 60 | Dr. Najat Khalifa OTHER |
2026-08-12 |
|
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease) NCT04748861 Indoor Cycling (IC) Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 150 | The Cleveland Clinic OTHER |
2026-08-12 |
|
Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife NCT05826379 Adaptive Daily Goal Setting; Interim Goal Prompt Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 200 | Milton S. Hershey Medical Center OTHER |
2026-08-12 |
|
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults NCT06027554 Mitoquinone Mesylate; Placebo capsule Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 60 | UConn Health OTHER |
2026-08-12 |
|
Early Age-Related Hearing Loss Investigation (EARHLI) NCT06174038 Hearing Intervention; Health Education Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Columbia University OTHER |
2026-08-12 |
|
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) NCT06402838 RO7269162; Placebo Runs in: Chile; Denmark; France; Germany; Italy; Poland; South Kor... · 46 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 256 | Hoffmann-La Roche INDUSTRY |
2026-08-12 |
|
Acute Hospital Care at Home for People Living With Dementia NCT06819852 Acute hospital care at home; Standard medical treatment Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 200 | Brigham and Women's Hospital OTHER |
2026-08-12 |
|
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 NCT07264283 LM11A-31; Matching Placebo Runs in: United States · 1 site |
PHASE2 other |
ENROLLING_BY_INVITATION | 147 | Adam Boxer OTHER |
2026-08-12 |
|
A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions NCT07370311 Chinese version of Making Choices Feeding Options for Patients with... Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Yaolin Pei OTHER |
2026-08-12 |
|
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia NCT04010305 Sublingual film containing BXCL501 (Dexmedetomidine); Placebo film Runs in: United States · 12 sites |
PHASE1 other |
COMPLETED | 135 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial